(<i>S</i>)-2-Amino-3-(3-hydroxy-7,8-dihydro-6<i>H</i>-cyclohepta[<i>d</i>]isoxazol-4-yl)propionic Acid, a Potent and Selective Agonist at the GluR5 Subtype of Ionotropic Glutamate Receptors. Synthesis, Modeling, and Molecular Pharmacology
Lotte Brehm, Povl Krogsgaard‐Larsen(NeuroSearch (Denmark)), Jan Egebjerg(NeuroSearch (Denmark)), Tine T. A. Kronborg(Lundbeck (Denmark)), Frank A. Sløk(Kyoto University), Jeremy R. Greenwood(Schrodinger (United States)), Hans Bräuner‐Osborne(University of Copenhagen), Kasper B. Hansen(Northwestern University), Tine B. Stensbøl(Kyoto University), Birgitte Nielsen(Kyoto University)
Cited by 26
Related Papers
Accurate and Reliable Prediction of Relative Ligand Binding Potency in Prospective Drug Discovery by Way of a Modern Free-Energy Calculation Protocol and Force Field
|Journal of the American Chemical Society|2015|1.4k
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels
|Pharmacological Reviews|2021|676
Structure, function, and allosteric modulation of NMDA receptors
|The Journal of General Physiology|2018|555
Ligands for Glutamate Receptors: Design and Therapeutic Prospects
|Journal of Medicinal Chemistry|2000|525
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488